Vaughan & Co Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $821K | Buy |
|
|||||
|
2025
Q2 | $716K | Sell |
|
|||||
|
2025
Q1 | $725K | Buy |
|
|||||
|
2024
Q4 | $470K | Sell |
|
|||||
|
2024
Q3 | $571K | Sell |
|
|||||
|
2024
Q2 | $540K | Sell |
|
|||||
|
2024
Q1 | $627K | Sell |
|
|||||
|
2023
Q4 | $610K | Sell |
|
|||||
|
2023
Q3 | $616K | Sell |
|
|||||
|
2023
Q2 | $613K | Sell |
|
|||||
|
2023
Q1 | $615K | Sell |
|
|||||
|
2022
Q4 | $845K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $726K | Sell |
|
|||||
|
2022
Q1 | $735K | Sell |
|
|||||
|
2021
Q4 | $750K | Buy |
|
|||||
|
2021
Q3 | $630K | Hold |
|
|||||
|
2021
Q2 | $656K | Hold |
|
|||||
|
2021
Q1 | $588K | Buy |
|
|||||
|
2020
Q4 | $414K | Sell |
|
|||||
|
2020
Q3 | $435K | Hold |
|
|||||
|
2020
Q2 | $471K | Sell |
|
|||||
|
2020
Q1 | $481K | Sell |
|
|||||
|
2019
Q4 | $598K | Buy |
|